C. Ferran et al., ANTITUMOR NECROSIS FACTOR MODULATES ANTI-CD3-TRIGGERED T-CELL CYTOKINE GENE-EXPRESSION IN-VIVO, The Journal of clinical investigation, 93(5), 1994, pp. 2189-2196
De novo expression of TNF, IFN gamma, IL-3, IL-4, and IL-6 genes was i
nitiated rapidly by treatment of mice with anti-CD3. A specific featur
e of this reaction was that TNF was derived exclusively from T cells.
TNF was produced both as a mature soluble trimeric protein and as a 26
-kD anti-TNF-reactive protein compatible with membrane-anchored TNF. P
retreatment with anti-TNF did not affect anti-CD3-triggered TNF mRNA e
xpression in T cells. In contrast, in vivo and in vitro anti-TNF treat
ment upregulated anti-CD3-induced IPN gamma mRNA expression and inhibi
ted IL-4 mRNA expression. These latter effects were not dependent on T
NF neutralization: pretreatment with soluble recombinant 55-kD TNF rec
eptor (TBPI) as an alternative TNF-neutralizing agent did not modify t
he anti-CD3-induced cytokine profile. These results suggest that a dir
ect interaction between anti-TNF and T cell membrane-anchored TNF coul
d account for the observed modulation of cytokine gene expression. The
increased expression of INF gamma mRNA observed in anti-TNF-treated a
nimals correlated with a decrease in IL-3 and IL-6 mRNA expression. Co
nversely, IFN I blockade by a neutralizing anti-IFN gamma mAb led to a
substantial increase in both IL-3 and IL-6 gene expression induced by
anti-CD3. Taken together, these results strongly argue for the existe
nce, in the anti-CD3-induced cytokine cascade, of IFN gamma-dependent
regulation of IL-3 production, which in turn modulates IL-6 production
.